Respiratory mechanics and ventilatory control in overlap syndrome and obesity hypoventilation

Respiratory Research

Walter T McNicholas²  Johan Verbraecken¹ 

[1] Department of Pulmonary Medicine and Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium;Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

关键词: Neurohormonal;    Respiratory drive;    OHS;    Apnea;    COPD;    Ventilatory control;    Respiratory mechanics;   

Others  :  792283
DOI  :  10.1186/1465-9921-14-132

 received in 2013-06-14, accepted in 2013-11-15,  发布年份 2013

【 摘 要 】

The overlap syndrome of obstructive sleep apnoea (OSA) and chronic obstructive pulmonary disease (COPD), in addition to obesity hypoventilation syndrome, represents growing health concerns, owing to the worldwide COPD and obesity epidemics and related co-morbidities. These disorders constitute the end points of a spectrum with distinct yet interrelated mechanisms that lead to a considerable health burden. The coexistence OSA and COPD seems to occur by chance, but the combination can contribute to worsened symptoms and oxygen desaturation at night, leading to disrupted sleep architecture and decreased sleep quality. Alveolar hypoventilation, ventilation-perfusion mismatch and intermittent hypercapnic events resulting from apneas and hypopneas contribute to the final clinical picture, which is quite different from the “usual” COPD. Obesity hypoventilation has emerged as a relatively common cause of chronic hypercapnic respiratory failure. Its pathophysiology results from complex interactions, among which are respiratory mechanics, ventilatory control, sleep-disordered breathing and neurohormonal disturbances, such as leptin resistance, each of which contributes to varying degrees in individual patients to the development of obesity hypoventilation. This respiratory embarrassment takes place when compensatory mechanisms like increased drive cannot be maintained or become overwhelmed.

Although a unifying concept for the pathogenesis of both disorders is lacking, it seems that these patients are in a vicious cycle. This review outlines the major pathophysiological mechanisms believed to contribute to the development of these specific clinical entities. Knowledge of shared mechanisms in the overlap syndrome and obesity hypoventilation may help to identify these patients and guide therapy.

【 授权许可】

   
2013 Verbraecken and McNicholas; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Verbraecken J, De Backer W: Upper airway mechanics. Respiration 2009, 78:121-133.
• [2]Zamarron C, Garcia Paz V, Morete E, del Campo MF: Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J COPD 2008, 3(4):671-682.
• [3]Weitzenblum E, Chaouat A, Kessler R, Canuet M: Overlap syndrome. Obstructive sleep apnea in patients with chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008, 5:237-241.
• [4]Olson AL, Zwillich C: The obesity hypoventilation syndrome. Am J Med 2005, 118:948-956.
• [5]Berger KI, Ayappa I, Chatr-Amontri B, Marfatia A, Sorkin IB, Rapoport DM, Goldring RM: Obesity hypoventilation syndrome as a spectrum of respiratory disturbances during sleep. Chest 2001, 120:1231-1238.
• [6]de Llano Pérez LA, Golpe R, Piquer MO, Racamonde AV, Caruncho MV, López MJ, Fariñas MC: Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications. Respiration 2008, 75:34-39.
• [7]Borel JC, Borel AL, Monneret D, Tamisier R, Levy P, Pepin JL: Obesity hypoventilation syndrome: from sleep-disordered breathing to systemic comorbidities and the need to offer combined treatment strategies. Respirology 2012, 17:601-610.
• [8]Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993, 323:1230-1235.
• [9]Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J 2006, 27:397-412.
• [10]Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ, Connell C, Jemal A, Lee TA, Miravitlles M, Aldington S, Beasley R: Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006, 27:188-207.
• [11]Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM: Five-year obesity incidence in the transition period between adolescence and adulthood: the national longitudinal study of adolescent health. Am J Clin Nutr 2004, 80:569-575.
• [12]Ogar CL, Fryar CD, Carroll MD, Flegal KM: Mean body weight, height and BMI, United States 1960-2002. Adv Data 2004, 347:1-17.
• [13]Davies RM, Novotny TE: The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 1989, 140:S82-S84.
• [14]Hiestand D, Philips B: The overlap syndrome: chronic obstructive pulmonary disease and obstructive sleep apnea. Crit Care Clin 2008, 24:551-563.
• [15]Marin JM, Carrizo SJ, Vicneti E, Agusti AG: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365:1046-1053.
• [16]Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR: Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010, 182(3):325-331.
• [17]Borel JC, Burel B, Tamisier R, Dias-Domingos S, Bauet JP, Levy P, Pepin JL: Comorbidities and mortality in hypercapnic obese under domiciliary non-invasive ventilation. Plose One 2013, 8(1):e52006. 1-8
• [18]American Academy of Sleep Medicine Task Force: Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American academy of sleep medicine task force. Sleep 1999, 22:667-689.
• [19]Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL, Tangredi MM: Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. J Clin Sleep Med 2012, 8(5):597-619.
• [20]Guilleminault C, Cummiskey J, Motta J: Chronic obstructive airflow disease and sleep studies. Am Rev Respir Dis 1980, 122:397-406.
• [21]Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R: Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am Rev Respir Dis 1995, 151:82-86.
• [22]Bradley TD, Rutherford A, Grossmann RF, Lue F, Zamel N, Moldosfsky H, Phillipson EA: Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1985, 131:835-839.
• [23]Bradley TD, Rutherford A, Lue F, Moldofsky H, Grossmann RF, Zamel N, Phillipson EA: Role of diffuse airway obstruction in the hypercapnia of obstructive apnea. Am Rev Respir Dis 1986, 134:920-924.
• [24]Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E: Sleep heart health study: sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003, 167:7-14.
• [25]Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson LG, Andersson S, Sandström T, Larsson K: Obstructive lung disease in Nothern Sweden studies: not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in Nothern Sweden studies. Respir Med 2003, 97(2):115-122.
• [26]McNicholas WT, Verbraecken J, Marin J: Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev 2013, 22:365-375.
• [27]Resta O, Barbaro MPF, Bonfitto P, Talamo S, Mastrosimone V, Stefano A, Giliberti T: Hypercapnia in obstructive sleep apnoea syndrome. Neth J Med 2000, 56:215-222.
• [28]O’Brien A, Whitman K: Lack of benefit of continuous positive airway pressure on lung function in patients with overlap syndrome. Lung 2005, 183:389-404.
• [29]Engelen MP, Schols AM, Does JD, Wouters EF: Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000, 71:733-738.
• [30]McNicholas WT: Chronic obstructive pulmonary disease and obstructive sleep apnea. Overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med 2009, 180:692-700.
• [31]Young T, Peppard PR, Gottlieb DJ: Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002, 165:1217-1239.
• [32]Wetter DW, Young TB, Bidwell TR, Badr MS, Palta M: Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994, 154:2219-2224.
• [33]Kim KS, Kim JH, Park SY, Won HR, Lee HJ, Yang HS, Kim HJ: Smoking induces oropharyngeal narrowing and increases the severity of obstructive sleep apnea syndrome. J Clin Sleep Med 2012, 8(4):367-374.
• [34]McNicholas WT: Impact of sleep in COPD. Chest 2000, 117:48S-53S.
• [35]Stege G, Vos PE, van den Elshout FJJ, Dekhuijzen PNR, van de Ven MJT, Heijdra YF: Sleep, hypnotics and chronic obstructive pulmonary disease. Respir Med 2008, 102(6):801-814.
• [36]Ballard RD, Clover CW, Suh BY: Influence of sleep on respiratory function in emphysema. Am J Respir Crit Care Med 1995, 151:945-951.
• [37]Calverley PM, Lee A, Towse L, van Noord J, Witek TJ, Kelsen S: Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003, 58(10):855-860.
• [38]Dawkins KD, Muers MF: Diurnal variation in airflow obstruction in chronic bronchitis. Thorax 1981, 36:618-621.
• [39]Postma DS, Koeter GH, van de Mark TW, Reig RP, Sluiter HJ: The effects of oral slow-release terbutaline on the circadian variation in spirometry and arterial blood gas levels in patients with chronic airflow obstruction. Chest 1985, 87(5):653-657.
• [40]Koo KW, Sax DS, Snider GL: Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975, 58(5):663-670.
• [41]Johnson MW, Remmers JE: Accessory muscle activity during sleep in chronic obstructive pulmonary disease. J Appl Physiol 1984, 57:1011-1017.
• [42]Ezzie ME, Parsons JP, Mastronarde JG: Sleep and obstructive lung diseases. Sleep Med Clin 2008, 3:505-515.
• [43]Hudgel DW, Devadatta P: Decrease in functional residual capacity during sleep in normal humans. J Appl Physiol 1984, 57:1319-1322.
• [44]Redolfi S, Yumino D, Ruttanaumpawan P, Yau B, Su MC, Lam J, Bradley TD: Relationship between overnight rostral fluid shift and obstructive sleep apnea in nonobese men. Am J Respir Crit Care Med 2009, 179:241-246.
• [45]Shujaat A, Minkin R, Eden E: Pulmonary hypertension and chronic cor pulmonale in COPD. Int J Chron Obstruct Pulmon Dis 2007, 2(3):273-282.
• [46]Weitzenblum E, Apprill M, Oswald M, Chaouat A, Imbs JL: Pulmonary hemodynamics in patients with chronic obstructive pulmonary disease before and during an episode of peripheral edema. Chest 1994, 105:1377-1382.
• [47]De Leeuw PW, Dees A: Fluid homeostasis in chronic obstructive lung disease. Eur Respir J 2003, 22(Suppl 46):33s-40s.
• [48]Novali M, Piana GL, Montemurro LT, Bertella E, Redolfi S, Corda L, Tantucci C: Predictive factors of sleep oxygen desaturation in COPD patients without daytime respiratory failure and OSAH [abstract]. Am J Respir Crit Care Med 2008, 177:A935.
• [49]Degache F, Sforza E, Dauphinot V, Celle S, Garcin A, Collet P, Pichot V, Barthélémy JC, Roche F, PROOF Study Group: Relation of central fat mass to obstructive sleep apnea in the elderly. Sleep 2013, 36(4):501-507.
• [50]Radwan L, Maszczyk Z, Koziorowski A, Koziej M, Cieslicki J, Sliwinski P, Zielinski J: Control of breathing in obstructive sleep apnoea and in patients with the overlap syndrome. Eur Respir J 1995, 8:542-545.
• [51]Verbraecken J, De Backer W, Willemen M, De Cock W, Wittesaele W, Van de Heyning P: Chronic CO2 drive in patients with obstructive sleep apnea and effect of CPAP. Respir Physiol 1995, 101:279-287.
• [52]Zwillich CW, Sutton FD, Pierson DJ, Greagh EM, Weil JV: Decreased hypoxic ventilatory drive in the obesity hypoventilation syndrome. Am J Med 1975, 59:343-348.
• [53]Erbland ML, Ebert RV, Snow SL: Interaction of hypoxia and hypercapnia on respiratory drive in patients with COPD. Chest 1990, 97:1289-1294.
• [54]Kessler R, Chaouat A, Schinkewitch P, Faller M, Casel S, Krieger J, Weitzenblum E: The obesity-hypoventilation syndrome revisited: a prospective study of 34 consecutive cases. Chest 2001, 120:369-376.
• [55]Soriano JB, Yáñez A, Renom F, de la Peña M, Gómez A, Duro R, Uréndez A, Román M: Set-up and pilot of a population cohort for the study of the natural history of COPD and OSA: the PULSAIB study. Prim Care Respir J 2010, 19(2):140-147.
• [56]Kwon JS, Wolf LF, Lu B, Kalhan R: Hyperinflation is associated with lower sleep efficiency in COPD with co-existent obstructive sleep apnea. J Chron Obstr Pulm Dis 2009, 6:441-445.
• [57]Tsai SC, Lee-Chiong T: Lung hyperinflation and sleep quality in the overlap syndrome. J Chron Obstr Pulm Dis 2009, 6:419-420.
• [58]Mermigkis C, Kopanakis A, Fodvary-Schaefer N, Golish J, Polychronopoulos V, Schiza S, Amfilochiou A, Siafakas N, Bouros D: Health-related quality of life in patients with obstructive sleep apnea and chronic obstructive pulmonary disease (overlap syndrome). Int J Clin Pract 2007, 61:207-211.
• [59]Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM: Postevent ventilation as a function of CO2 load during respiratory events in obstructive sleep apnea. J Appl Physiol 2002, 93:917-924.
• [60]Series F, Cormier Y, La Forge J: Role of lung volumes in sleep apnoea related oxygen desaturation. Eur Respir J 1989, 2:26-30.
• [61]Series F, Marc I: Influence of lung volume dependence of upper airway resistance during continuous negative airway pressure. J Appl Physiol 1994, 77:840-844.
• [62]Heinzer RC, Stanchina ML, Malhotra A, Jordan AS, Patel SR, Lo YL, Wellman A, Schory K, Dover L, White DP: Effect of increased lung volume on sleep disordered breathing in sleep apnoea patients. Thorax 2006, 61:435-439.
• [63]Bednarek M, Plywaczewski R, Jonczak L, Zielinski J: There is no relationshiop between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study. Respiration 2005, 72:142-149.
• [64]Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW: Respiration during sleep in normal man. Thorax 1982, 37:840-844.
• [65]Douglas J, White DP, Weil JV, Pickett CK, Zwillich CW: Hypercapnic ventilatory response in sleeping adults. Am Rev Respir Dis 1982, 126:758-762.
• [66]Berger KI, Ayappa I, Sorkin IB, Norman RG, Rapoport DM, Goldring RM: CO(2) homeostasis during periodic breathing in obstructive sleep apnea. J Appl Physiol 2000, 88(1):257-264.
• [67]Berger KI, Norman RG, Ayappa I, Oppenheimer BW, Rapoport DM, Goldring RM: Potential mechanism for transition between acute hypercapnia during sleep to chronic hypercapnia during wakefulness in obstructive sleep apnea. Adv Exp Med Biol 2008, 605:431-436.
• [68]Weil JV, Byrne-Quin IE, Sodal IE, Filley GF, Grover RF: Acquired attenuation of chemoreceptor function in chronically hypoxic man at high altitude. J Clin Invest 1971, 50:186-195.
• [69]Gold AR, Schwartz AR, Bleecker ER, Smith PL: The effect of chronic nocturnal oxygen administration upon sleep apnea. Am Rev Respir Dis 1986, 134:925-929.
• [70]Leech JA, Onal E, Lopata M: Nasal CPAP continues to improve sleep-disordered breathing and daytime oxygenation over long-term follow-up of occlusive sleep apnea syndrome. Chest 1992, 102:1651-1655.
• [71]Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Levi-Valensi P, Zielinski J, Delaunois L, Cornudella R, Moutinho dos Santos J: Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997, 10:1730-1735.
• [72]Garay SM, Rapoport D, Sorkin B, Epstein H, Feinberg I, Goldring RM: Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 1981, 124:451-457.
• [73]Lopata M, Onal E: Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 1982, 126:640-645.
• [74]Guilleminault C, Cummiskey J: Progressive improvement in apnea index and ventilatory response to CO2 after tracheostomy in obstructive sleep apnea. Am Rev Respir Dis 1982, 126:14-20.
• [75]Mountain R, Zwillich CW, Weil JV: Hypoventilation in obstructive lung disease. The role of familial factors. N Engl J Med 1978, 298:521-525.
• [76]Hawrylkiewicz I, Sliwinski P, Gorecka D, Pływaczewski R, Zieliński J: Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch Chest Dis 2004, 61:148-152.
• [77]Chaouat A, Naeije R, Weitzenblum E: Pulmonary hypertension in COPD. Eur Respir J 2008, 32(5):1371-1385.
• [78]Shiina K, Tomiyama H, Takata Y, Yoshida M, Kato K, Nishihata Y, Matsumoto C, Odaira M, Saruhara H, Hashimura Y, Usui Y, Yamashina A: Overlap syndrome: additive effects of COPD on the cardiovascular damages in patients with OSA. Respir Med 2012, 106(9):1335-1341.
• [79]Sharma B, Neilan TG, Kwong RY, Mandry D, Owens RL, McSharry D, Bakker JP, Malhotra A: Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD 2013, 10(1):4-10.
• [80]Ganga HV, Nair SU, Puppala VK, Miller WL: Risk of new-onset atrial fibrillation in elderly patients with the overlap syndrome: a retrospective cohort study. J Geriatr Cardiol 2013, 10(2):129-134.
• [81]Piper AJ, Grunstein RR: Obesity hypoventilation syndrome. Mechanisms and management. Am J Respir Crit Care Med 2011, 183:292-298.
• [82]Piper AJ, Grunstein RR: Big breathing: the complex interaction of obesity, hypoventilation, weight loss, and respiratory function. J Appl Physiol 2010, 108:199-205.
• [83]Cherniak NS: What causes hypercapnia? Won’t breathe, can’t breathe or something in between? Respiration 2008, 75:251-252.
• [84]Martin TJ, Sanders MH: Chronic alveolar hypoventilation: a review for the clinician. Sleep 1995, 18:617-634.
• [85]Teichtahl H: The obesity-hypoventilation syndrome revisited. Chest 2001, 120(2):336-339.
• [86]Leech J, Önal E, Aronson R, Lopata M: Voluntary hyperventilation in obesity hypoventilation. Chest 1991, 100:1334-1338.
• [87]Yee BJ, Cheung J, Philipps P, Banerjee D, Piper AJ: Treatment of obesity hypoventilation syndrome and serum leptin. Respiration 2006, 73:209-212.
• [88]de Llano Pérez LA, Golpe R, Ortiz Piquer M, Veres Racamonde A, Vázquez Caruncho M, Caballero Muinelos O, Alvarez Carro C: Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Chest 2005, 128:587-594.
• [89]Selim BJ, Junna MR, Morgenthaler TI: Therapy for sleep hypoventilation and central apnea syndromes. Curr Treat Options Neurol 2012, 14(5):427-437.
• [90]Contal O, Adler D, Borel JC, Espa F, Perrig S, Rodenstein D, Pépin JL, Janssens JP: Impact of different backup respiratory rates on the efficacy of non-invasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest 2013, 143(1):37-46.
• [91]Windisch W, Storre JH: Target volume settings for home mechanical ventilation: great progress or just a gadget? Thorax 2012, 67(8):663-665.
• [92]Esquinas AM: Backup respiratory rate during non-invasive positive pressure ventilation in obesity hypoventilation syndrome: can this difficult puzzle be resolved? Chest 2013, 143(4):1182-1183.
• [93]Laaban JP, Chailleux E: Observatory group of Antadir: daytime hypercapnia in adults patients with obstructive sleep apnea syndrome in France, before initiating nocturnal nasal continuous positive airway pressure therapy. Chest 2005, 127:710-715.
• [94]Mokhlesi B, Tulaimat A, Faibussowitsch I, Wang Y, Evans A: Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007, 11:117-124.
• [95]Macavei VM, Spurling KJ, Loft J, Makker HK: Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med 2013, 9(9):879-884.
• [96]Nowbar S, Burkart KM, Gonzales R, Fedorowicz A, Gozansky WS, Gaudio JC, Taylor MR, Zwillich CW: Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am J Med 2004, 116:1-7.
• [97]Kaw R, Hernandez AV, Walker E, Aboussouan L, Mokhlesi B: Determinants of hypercapnia in obese patients with obstructive sleep apnea: a systematic review and metaanalysis of cohort studies. Chest 2009, 136:787-796.
• [98]Mokhlesi B, Saager L, Kaw RQ: Should we routinely screen for hypercapnia in sleep apnea patients before elective noncardiac surgery? Cleve Clin J Med 2010, 77:60-61.
• [99]Jones RL, Nzekuwu MU: The effects of body mass index on lung volumes. Chest 2006, 130(3):827-833.
• [100]Piper AJ: Obesity hypoventilation syndrome – the big and the breathless. Sleep Med Rev 2011, 15:79-89.
• [101]Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ: Total respiratory system inertance and its gas and tissue components in normal and obese men. J Clin Invest 1964, 43:503-509.
• [102]Case KR, Ortiz K, Brown LK: Sleep-related hypoventilation/hypoxemic syndromes. Chest 2007, 131:1936-1948.
• [103]Lazarus R, Sparrow D, Weiss ST: Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997, 111:891-898.
• [104]Rubinstein I, Zamel N, DuBarry L, Hoffstein V: Airflow limitation in morbidly obese, nonsmoking men. Ann Intern Med 1990, 112:828-832.
• [105]Behazin N, Jones SB, Cohen RI, Loring SH: Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol 2010, 108:212-218.
• [106]Pelosi P, Croci M, Ravagnan I, Vicardi P, Gattinoni L: Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed post-operative morbidly obese patients. Chest 1996, 109:144-151.
• [107]Zerah F, Harf A, Perlemuter L, Lorino H, Lorino AM, Atlan G: Effects of obesity on respiratory resistance. Chest 1993, 103:1470-1476.
• [108]Thomas PS, Cowen ERT, Hulands G, Milledge JS: Respiratory function in the morbidly obese before and after weight loss. Thorax 1989, 4:382-386.
• [109]Resta O, Foschino-Barbaro MP, Bonfitto P, Talamo S, Legari G, De Pergola G, Minenna A, Giorgino R: Prevalence and mechanisms of diurnal hypercapnia in a sample of morbidly obese subjects with obstructive sleep apnoea. Respir Med 2000, 94:240-246.
• [110]Sharp JT, Henry JP, Sweany SK, Meadows WR, Pietras RJ: The total work of breathing in normal and obese men. J Clin Invest 1964, 43:728-739.
• [111]Pankow W, Podszus T, Gutheil T, Penzel T, Peter J, von Wichert P: Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. J Appl Physiol 1998, 85:1236-1243.
• [112]Chlif M, Keochkerian D, Choquet D, Vaidie A, Ahmaidi S: Effects of obesity on breathing pattern, ventilatory neural drive and mechanics. Respir Physiol Neurobiol 2009, 168:198-202.
• [113]Pankow W, Hijjeh N, Schuttler F, Penzel T, Becker HF, Peter JH, von Wichert P: Influence of noninvasive positive pressure ventilation in obese subjects. Eur Respir J 1997, 10:2847-2852.
• [114]Sampson MG, Grassino AE: Load compensation in obese patients during quiet tidal breathing. J Appl Physiol 1983, 55:1269-1276.
• [115]Lee MY, Linn CC, Shen SY, Chiu CH, Liaw SF: Work of breathing in eucapnic and hypercapnic sleep apnea syndrome. Respiration 2009, 77:146-153.
• [116]Sampson MG, Grassino K: Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med 1983, 75:81-90.
• [117]Kress JP, Pohlman AS, Alverdy J, Hall JB: The impact of morbid obesity on oxygen cost of breathing (Vo2RESP) at rest. Am J Respir Crit Care Med 1999, 160:883-886.
• [118]Lin CC, Wu KM, Chou CS, Liaw SF: Oral airway resistance during wakefulness in eucapnic and hypercapnic sleep apnea syndrome. Respir Physiol 2004, 139:215-224.
• [119]Lin WY, Yao CA, Wang HC, Huang KC: Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity 2006, 14:1654-1661.
• [120]Monneret D, Borel JC, Pepin JL, Tamisier R, Arnol N, Levy P, Faure P: Pleiotropic role of IGF-I in obesity hypoventilation syndrome. Growth Horm IGF Res 2010, 20:127-133.
• [121]Ameredes BT, Watchko JF, Daood MJ, Rosas JF, Donahoe MP, Rogers RM: Growth hormone restores aged diaphragm myosin composition and performance after chronic denutrition. J Appl Physiol 1999, 87:1253-1259.
• [122]Laffey J, Kavanagh B: Permissive Hypercapnia. In Principles and Practice of Mechanical Ventilation. Edited by Tobin MJ. New York: McGraw Hill; 2006:373-392.
• [123]Sharp JT, Druz WS, Kondragunta VR: Diaphragmatic responses to body position changes in obese patients with obstructive sleep apnea. Am Rev Respir Dis 1986, 133:32-37.
• [124]Zakorsky GS, Wilson B: Sex, girth, waists and hips (what matters for gas exchange in extreme obesity?). Respir Physiol 2010, 170:120-122.
• [125]Heinemann F, Budweiser S, Dobroschke J, Pfeifer M: Non-invasive positive pressure ventilation improves lung volumes in the obesity hypoventilation syndrome. Respir Med 2007, 101:1229-1235.
• [126]BaHamman A: Acute ventilatory failure complicating obesity hypoventilation: update on a ‘critical care syndrome’. Curr Opin Pulm Med 2010, 16:543-551.
• [127]Steier J, Jolley CJ, Seymour J, Roughton M, Polkey MI, Moxham J: Neural respiratory drive in obesity. Thorax 2009, 64:719-725.
• [128]Rapoport DM, Garay SM, Epstein H, Goldring RM: Hypercapnia in the obstructive sleep apnea syndrome: a reevaluation of the “Pickwickian syndrome”. Chest 1986, 89:627-635.
• [129]Berthon-Jones M, Sullivan CE: Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis 1987, 135:144-147.
• [130]Lin CC: Effect of nasal CPAP on ventilatory drive in normocapnic and hypercapnic patients with obstructive sleep apnoea syndrome. Eur Respir J 1994, 7:2005-2010.
• [131]De Lucas-Ramos P, de Miguel-Diez J, Santacruz-Siminiani A, González-Moro JM, Buendía-García MJ, Izquierdo-Alonso JL: Benefits at 1 year of nocturnal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome. Respir Med 2004, 98:961-967.
• [132]Jokic R, Zintel T, Sridhar G, Gallagher CG, Fitzpatrick MF: Ventilatory responses to hypercapnia and hypoxia in relatives of patients with the obesity hypoventilation syndrome. Thorax 2000, 55:940-945.
• [133]Han F, Chen E, Wei H, He Q, Ding D, Strohl KP: Treatment effects on carbon dioxide retention in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2001, 119:1814-1819.
• [134]Chouri-Pontarollo N, Borel JC, Tamisier R, Wuyam B, Levy P, Pepin JL: Impaired objective daytime vigilance in obesity-hypoventilation syndrome: impact of non-invasive ventilation. Chest 2007, 131:148-155.
• [135]Raurich JM, Rialp G, Ibanez J, Llompart-Pou JA, Ayestaran I: Hypercapnic respiratory failure in obesity hypoventilation syndrome: CO2 response and acetazolamide treatment effects. Repir Care 2010, 55(11):1442-1448.
• [136]Inyushkin AN, Inyushkin EM, Merkulova NA: Respiratory responses to microinjections of leptin into the solitary tract nucleus. Neurosci Behav Physiol 2009, 39:231-240.
• [137]Atwood CW: Sleep-related hypoventilation: the evolving role of leptin. Chest 2005, 128:1079-1081.
• [138]Kalra SP: Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions. Peptides 2008, 29:127-138.
• [139]O’Donnell CP, Schaub CD, Haines AS, Berkowitz DE, Tankersley CG, Schwartz AR, Smith PL: Leptin prevents respiratory depression in obesity. Am J Respir Crit Care Med 1999, 159:1477-1484.
• [140]Lévy P, Pépin JL, Arnoud C, Tamisier R, Borel JC, Dematteis M, Godin-Ribuot D, Ribuot C: Intermittent hypoxia and sleep-disordered breathing: current concepts and perspectives. Eur Respir J 2008, 32:1082-1095.
• [141]Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ration: a possible mechanism for leptin resistance. Lancet 1996, 348:159-161.
• [142]Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr: Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 1996, 2:589-593.
• [143]Lin CK, Lin CC: Work of breathing and respiratory drive in obesity. Respirology 2012, 17:402-411.
• [144]Polotsky VY, Wilson JA, Smadone MC, Haines AS, Hurn PD, Tankersley GG, Smith PL, Schwartz AR, O'Donnell CP: Female gender exacerbates respiratory depression in leptin-deficient obesity. Am J Respir Crit Care Med 2001, 164:1470-1475.
• [145]Malli F, Papaioannou AI, Gourgoulianis KI, Daniil Z: The role of leptin in the respiratory system: an overview. Respir Res 2010, 11(152):1-16.
• [146]Popko K, Gorska E, Wasik M, Stoklosa A, Plywaczewsi R, Winiarska M, Gorecka D, Sliwinski P, Demkow U: Frequency of distribution of leptin receptor gene polymorphism in obstructive sleep apnoea patients. J Physiol Pharmacol 2007, 58(5):551-561. Pt 2
• [147]Campo A, Fruhbeck G, Zulueta JJ, Iriarte J, Seijo LM, Alcaide AB, Galdiz JB, Salvador J: Hyperleptinemia, respiratory drive and hypercapnic response in obese patients. Eur Respir J 2007, 30:223-231.
• [148]Redolfi S, Corda L, La Piana G, Spandrio S, Prometti P, Tantucci C: Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity hypoventilation syndrome. Respir Med 2007, 101:1191-1195.
• [149]Verbraecken J, Willemen M, De Cock W, Wittesaele W, Govaert K, Van de Heyning P, De Backer W: Influence of long-term CPAP therapy on CO2 drive in patients with obstructive sleep apnea. Respir Physiol 2000, 123:121-130.
• [150]Marti-Valeri C, Sabate A, Masdevall C, Dalmau A: Improvement of associated respiratory problems in morbidly obese patients after open Roux-en-Y gastric bypass. Obes Surg 2007, 17(8):1102-1110.
• [151]Chapman KR, Himal HS, Rebuck AS: Ventilatory responses to hypercapnia and hypoxia in patients with eucapnic morbid obesity before and after weight loss. Clin Sci (Lond) 1990, 78(6):541-545.
• [152]Hlavac MC, Cathceside PG, McDonald R, Eckert DJ, Windler S, McEvoy RD: Hypoxia impairs the arousal response to external resistive loading and airway occlusion during sleep. Sleep 2006, 29:624-631.
• [153]Piper AJ: Nocturnal hypoventilation – identifying & treating syndromes. Indian J Med Res 2010, 131:350-365.
• [154]Rabec C, de Lucas RP, Veale D: Respiratory complications of obesity. Arch Bronchoneumol 2011, 47(5):252-261.
• [155]Hanaoka M, Yu X, Urushihata K, Ota M, Fujimoto K, Kubo K: Leptin and leptin receptor gene polymorphisms in obstructive sleep apnoea syndrome. Chest 2008, 133(1):79-85.
• [156]Fitzpatrick M: Leptin and the obesity hypoventilation syndrome: a leap of faith? Thorax 2002, 57(1):1-2.
• [157]Phipps PR, Starritt E, Caterson I, Grunstein RR: Association of serum leptin with hypoventilation in human obesity. Thorax 2002, 57:75-76.
• [158]Thut DC, Schwartz AR, Roach D, Wise RA, Permutt S, Smith PL: Tracheal and neck position influence upper airway airflow dynamics by altering airway length. J Appl Physiol 1993, 75:2084-2090.
• [159]Cooper KR, Phillips BA: Effect of short-term sleep loss on breathing. J Appl Physiol 1982, 53:855-858.
• [160]Akashiba T, Kawahara S, Kosaka N, Ito D, Saito O, Majima T, Horie T: Determinants of chronic hypercapnia in Japanese men with obstructive sleep apnea syndrome. Chest 2002, 121(2):415-421.
• [161]Mutlu GM, Rubinstein I: The Saga of obstructive sleep apnea syndrome and daytime hypercapnia. Work in progress. Chest 2005, 127(3):698-699.
• [162]Sin DD, Jones RL, Man GC: Hypercapnic ventilatory response in patients with and without obstructive sleep apnea: do age, gender, obesity, and daytime PaCO(2) matter? Chest 2000, 117(2):454-459.
• [163]Katawata N, Tatsumi K, Terada J, Tada Y, Tanabe N, Takiguchi Y, Kuriyama T: Daytime hypercapnia in obstructive sleep apnea syndrome. Chest 2007, 132(6):1832-1838.
• [164]Mokhlesi B, Kryger MH, Grunstein RR: Assessment and management of patients with obesity hypoventilation syndrome. Proc Am Thor Soc 2008, 5:218-225.
• [165]Rapoport D: Obesity hypoventilation syndrome: more than just severe sleep apnea. Sleep Med Rev 2011, 15(2):77-78.
• [166]De Miguel DJ, De Lucas RP, Perez Parra JJ, Buendia Garcia MJ, Cubillo Marcos JM, Gonzalez-Moro JM: Analysis of withdrawal from non-invasive mechanical ventilation in patients with obesity-hypoventilation syndrome: medium term results. Arch Bronconeumol 2003, 39:292-297.
• [167]Lee SD, Nakano H, Farkas GA: Adenosinergic modulation of ventilation in obese Zucker rats. Obes Res 2005, 13:545-555.
• [168]Norman RG, Goldring RM, Clain JM, Oppenheimer BW, Charney AN, Rapoport DM, Berger KI: Transition from acute to chronic hypercapnia in patients with periodic breathing: predictions from a computer model. J Appl Physiol 2006, 100:1733-1741.
• [169]Ayappa I, Berger KI, Norman RG, Oppenheimer BW, Rapoport DM, Goldring RM: Hypercapnia and ventilatory periodicity in obstructive sleep apnea syndrome. Am J Respir Crit Cared Med 2002, 166:1112-1115.
• [170]Gifford AH, Leitter JC, Manning HL: Respiratory function in an obese patient with sleep-disordered breathing. Chest 2010, 138(3):704-715.
• [171]Berger KI, Goldring RM, Rapoport DM: Obesity hypoventilation syndrome. Semin Respir Crit Care Med 2009, 30:253-261.
• [172]Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S: Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol heart Circ Physiol 2005, 288:H2031-H2041.
• [173]Higashiura K, Ura N, Ohata J, Togashi N, Takagi S, Saitoh S, Murakami H, Takeaway Y, Shimamoto K: Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf) 2004, 61:753-759.
• [174]Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I: Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
• [175]Chen B, Lam KS, Wang Y, Wu D, Lam MC, Shen J, Wong L, Hoo RL, Zhang J, Xu A: Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes. Biochem Biophys Res Commun 2006, 341:549-556.
• [176]Borel JC, Roux-Lombard P, Tamisier R, Arnaud C, Monneret D, Arnol N, Baguet JP, Levy P, Pepin JL: Endothelial dysfunction and specific inflammation in obesity hypoventilation. PLoS One 2009, 4(8):e6733.
• [177]Basoglu OK, Tasbakan MS: Comparison of clinical characteristics in patients with obesity hypoventilation syndrome and obese obstructive sleep apnea syndrome: a case-control study. Clin Respir J 2013. in press
• [178]Chau EHL, Lam D, Wong J, Mokhlesi B, Chung F: Obesity hypoventilation syndrome. A review of epidemiology, pathophysiology, and perioperative considerations. Anesthesiology 2012, 17(1):188-205.
• [179]Mokhlesi B, Tulaimat A: Recent advances in obesity hypoventilation syndrome. Chest 2007, 132(4):1322-1336.
• [180]Kauppert CA, Dvorak I, Kollert F, Heinemann F, Jörres RA, Pfeifer M, Budweiser S: Pulmonary hypertension in obesity-hypoventilation syndrome. Respir Med 2013. in press
• [181]O’Donoghue FJ, Catcheside PG, Ellis EE, Grunstein RR, Pierce RJ, Rowland LS, Collins ER, Rochford SE, McEvoy RD: Australian trial of noninvasive ventilation in chronic airflow limitation investigators: sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors. Eur Respir J 2003, 21:977-984.
• [182]Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997, 157(15):1746-1752.
• [183]Borel JC, Tamisier R, Gonzalez-Bermejo J, Baguet JP, Monneret D, Arnol N, Roux-Lombard P, Wuyam B, Levy P, Pépin JL: Noninvasive ventilation in mild obesity hypoventilation syndrome. A rondomized controlled trial. Chest 2012, 141(3):692-702.
• [184]Machado MC, Vollmer WM, Togeiro SM, Bilderback AL, Oliveira MV, Leitão FS, Queiroga F Jr, Lorenzi-Filho G, Krishnan JA: CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010, 35(1):132-137.
• [185]Stanchina ML, Welicky LM, Donat W, Lee D, Corrao W, Malhotra A: Impact of CPAP use and age on mortality in patients with combined COPD and obstructive sleep apnea: the overlap syndrome. J Clin Sleep Med 2013, 9(8):767-772.
• [186]Hida W, Okabe S, Tatsumi K, Kimura H, Akasiba T, Chin K, Ohi M, Nakayama H, Satoh M, Kuriyama T: Nasal continuous positive airway pressure improves quality of life in obesity hypoventilation syndrome. Sleep Breath 2003, 7(1):3-12.
• [187]Berg G, Delaive K, Manfreda J, Walld R, Kryger MH: The use of health-care resources in obesity- hypoventilation syndrome. Chest 2001, 120(2):377-383.
• [188]Shaya FT, Lin PJ, Aljawadi MH, Scharf SM: Elevated economic burden in obstructive lung disease patients with concomitant sleep apnea syndrome. Sleep Breath 2009, 13(4):317-323.
• [189]Pepin JL, Borel JC, Janssens JP: Obesity hypoventilation syndrome: an underdiagnosed and undertreated condition. Am J Respir Crit Care Med 2012, 186(12):1205-1207.